Viewing Study NCT01458366


Ignite Creation Date: 2025-12-24 @ 4:03 PM
Ignite Modification Date: 2026-04-14 @ 2:50 AM
Study NCT ID: NCT01458366
Status: COMPLETED
Last Update Posted: 2025-04-30
First Post: 2011-09-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide
Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization: